Cargando…
Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway
Osteosarcoma (OS) is a primary malignant tumor that occurs in bone, and mainly affects children and adolescents. C-type lectin domain family 3 member A (CLEC3A) is a member of the C-type lectin superfamily, which regulates various biological functions of cells. The present study aimed to identify th...
Autores principales: | Ren, Chong, Pan, Runsang, Hou, Lisong, Wu, Huaping, Sun, Junkang, Zhang, Wenguang, Tian, Xiaobin, Chen, Houping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057774/ https://www.ncbi.nlm.nih.gov/pubmed/32319617 http://dx.doi.org/10.3892/mmr.2020.10986 |
Ejemplares similares
-
MicroRNA-145-5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3
por: Li, Hao, et al.
Publicado: (2020) -
CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway
por: Chen, Houping, et al.
Publicado: (2021) -
Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2
por: Pan, Runsang, et al.
Publicado: (2021) -
Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway
por: Yan, Xianke, et al.
Publicado: (2020) -
CLEC5A regulates the proliferation and migration of colon cancer via the AKT/mTOR signaling pathway
por: Pan, Yang, et al.
Publicado: (2023)